Wednesday, February 24, 2021  |  1:00PM - 2:00PM
$ | 500 seats remaining

As a sterile compounding professional, patient safety is the number-one priority. Many organizations purchase compounded sterile preparations (CSPs) from 503B outsourcing facilities and rely on them as a partner, trusting that they have the appropriate quality systems in place to ensure preparation of a safe and efficacious medication. What many fail to realize is that the quality of the CSP from the outsourcer is still the responsibility of the purchasing organization. Choosing a 503B outsourcing facility requires a thorough evaluation of the facility and its quality system. In this webinar, we will discuss how to evaluate an outsourcing facility, including how to make the most of a visit and how to interpret the outsourcer's history with the FDA.

Presented by Eric Kastango, MBA, BS Pharm, FASHP